Quarterly report pursuant to Section 13 or 15(d)

Statements of Mezzanine Equity and Stockholders??? Deficit (Unaudited)

v3.24.3
Statements of Mezzanine Equity and Stockholders’ Deficit (Unaudited) - USD ($)
$ in Thousands
Series A-1 Preferred Stock
Common Stock
Series A-2 Preferred Stock
Additional Paid-In Capital
Accumulated Deficit
Series B-1 Preferred Stock
Series A-2 Prime Preferred Stock
Series B-2 Preferred Stock
Total
Balance at Dec. 31, 2022 $ 15 $ 33,516 $ (33,997)       $ (466)
Balance (in Shares) at Dec. 31, 2022 15,231,655            
Net income (loss) (14,575)       (14,575)
Issuance of Series A-1 preferred stock, net of issuance costs and allocated fair value of warrant liability $ 25,407      
Issuance of Series A-1 preferred stock, net of issuance costs and allocated fair value of warrant liability (in Shares) 30,190            
Deemed dividends on Series A-1 preferred stock $ 192 (192)       (192)
Issuance of common stock for exercise of options 7       7
Issuance of common stock for exercise of options (in Shares) 2,181            
Stock-based compensation expense 144       144
Balance at Mar. 31, 2023 $ 25,599 $ 15 33,475 (48,572)       (15,082)
Balance (in Shares) at Mar. 31, 2023 30,190 15,233,836            
Balance at Dec. 31, 2022 $ 15 33,516 (33,997)       (466)
Balance (in Shares) at Dec. 31, 2022 15,231,655            
Net income (loss)                 (22,746)
Balance at Sep. 30, 2023 $ 35 $ 44 60,098 (56,743)       3,434
Balance (in Shares) at Sep. 30, 2023 34,754,401 43,649            
Balance at Mar. 31, 2023 $ 25,599 $ 15 33,475 (48,572)       (15,082)
Balance (in Shares) at Mar. 31, 2023 30,190 15,233,836            
Net income (loss) (3,838)       (3,838)
Deemed dividends on Series A-1 preferred stock 603 (603)       (603)
Issuance of common stock for exercise of options 7       7
Issuance of common stock for exercise of options (in Shares) 2,180            
Stock-based compensation expense 144       144
Balance at Jun. 30, 2023 $ 26,202 $ 15 33,023 (52,410)       (19,372)
Balance (in Shares) at Jun. 30, 2023 30,190 15,236,016            
Net income (loss) (4,333)       (4,333)
Deemed dividends on Series A-1 preferred stock 72 (72)       (72)
Issuance of Series A-2 preferred stock and common stock upon conversion of Series A-1 preferred stock $ (26,274) $ 20 $ 44 26,211       26,275
Issuance of Series A-2 preferred stock and common stock upon conversion of Series A-1 preferred stock (in Shares) (30,190) 19,516,205 43,649            
Issuance of common stock for exercise of options 7       7
Issuance of common stock for exercise of options (in Shares) 2,180            
Stock-based compensation expense 929       929
Balance at Sep. 30, 2023 $ 35 $ 44 60,098 (56,743)       3,434
Balance (in Shares) at Sep. 30, 2023 34,754,401 43,649            
Balance at Dec. 31, 2023   $ 35 60,697 (64,541) (3,809)
Balance (in Shares) at Dec. 31, 2023   34,756,049 43,649      
Net income (loss)   (20,963)   (20,963)
Issuance of Series B-1 preferred stock, net of issuance costs   $ 46,187
Issuance of Series B-1 preferred stock, net of issuance costs (in Shares)       50,000  
Dividends on Series B-1 preferred stock   (208) (208)
Exchange of Series A-2 preferred stock for Series A-2 Prime preferred stock  
Exchange of Series A-2 preferred stock for Series A-2 Prime preferred stock (in Shares)   (43,649)     21,388.01  
Conversion of Series A-2 Prime preferred stock into common stock   $ 2 (2)
Conversion of Series A-2 Prime preferred stock into common stock (in Shares)   2,850,000     (1,396.5)  
Issuance of common stock for exercise of options   2 2
Issuance of common stock for exercise of options (in Shares)   581      
Stock-based compensation expense   522 522
Balance at Mar. 31, 2024   $ 37 61,011 (85,504) $ 46,187 (24,456)
Balance (in Shares) at Mar. 31, 2024   37,606,630     50,000 19,991.51  
Balance at Dec. 31, 2023   $ 35 60,697 (64,541) (3,809)
Balance (in Shares) at Dec. 31, 2023   34,756,049 43,649      
Net income (loss)                 $ (15,204)
Issuance of common stock for exercise of options (in Shares)                 1,357
Balance at Sep. 30, 2024   $ 98 104,497 (79,745) $ 27,850
Balance (in Shares) at Sep. 30, 2024   97,858,406     11,111.24 7,882  
Balance at Mar. 31, 2024   $ 37 61,011 (85,504) $ 46,187 (24,456)
Balance (in Shares) at Mar. 31, 2024   37,606,630     50,000 19,991.51  
Net income (loss)   9,855   9,855
Dividends on Series B-1 preferred stock   (887) (887)
Conversion of Series A-2 Prime preferred stock into common stock   $ 6 (6)
Conversion of Series A-2 Prime preferred stock into common stock (in Shares)   5,956,000     (2,918.44)  
Issuance of common stock for exercise of options   1 1
Issuance of common stock for exercise of options (in Shares)   10,582      
Stock-based compensation expense   641 641
Balance at Jun. 30, 2024   $ 43 60,760 (75,649) $ 46,187 (14,846)
Balance (in Shares) at Jun. 30, 2024   43,573,212     50,000 17,073.07  
Net income (loss)   (4,096) (4,096)
Issuance of Series B-2 preferred stock and common stock upon conversion of Series B-1 preferred stock   $ 55 46,132 $ (46,187) 46,187
Issuance of Series B-2 preferred stock and common stock upon conversion of Series B-1 preferred stock (in Shares)   54,285,000     (50,000) (5,961.83) 7,882  
Issuance of common stock for exercise of options  
Issuance of common stock for exercise of options (in Shares)   194      
Stock-based compensation expense   605 605
Balance at Sep. 30, 2024   $ 98 $ 104,497 $ (79,745) $ 27,850
Balance (in Shares) at Sep. 30, 2024   97,858,406     11,111.24 7,882